Optiver Holding B.V. Cogent Biosciences, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 748 shares of COGT stock, worth $23,576. This represents 0.0% of its overall portfolio holdings.
Number of Shares
748Holding current value
$23,576% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding COGT
# of Institutions
207Shares Held
122MCall Options Held
2.76MPut Options Held
828K-
Paradigm Biocapital Advisors LP New York, NY10.4MShares$326 Million3.47% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.49MShares$268 Million7.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.76MShares$245 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$230 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$220 Million10.2% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $2.07B
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...